US Broker Ratings

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Remarkable 161% Potential Upside in Biotech

Investors with a keen eye on the biotechnology sector may want to take a closer look at Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Uncovering a Remarkable 255% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing the attention of investors with an intriguing proposition in the healthcare sector, particularly within the biotechnology industry. Specializing in..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Eyeing an 89.79% Potential Upside in Healthcare Innovation

Castle Biosciences, Inc. (NASDAQ: CSTL) stands at the forefront of the molecular diagnostics industry, specializing in innovative solutions for dermatologic cancers and other critical health conditions...

LENZ Therapeutics, Inc. (LENZ): Investor Outlook on a Biotech with 48% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biopharmaceutical industry, stands out with its promising therapies aimed at improving vision. Headquartered in Solana Beach,..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a Potential 161% Upside for Investors

AxoGen, Inc. (NASDAQ: AXGN), a pioneering entity in the medical devices sector, is garnering significant attention from investors due to its promising growth trajectory and substantial..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unveiling 11.66% Potential Upside for Investors

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves within the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $618.01 million,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 30.6% Potential Upside with Analyst Insights

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a key player in the healthcare staffing industry, offers a compelling narrative for investors seeking opportunities within the healthcare sector...

Claritev Corporation (CTEV) Stock Analysis: Navigating the Healthcare Data Landscape Amidst a 52-Week High

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services industry, has captured investor attention with its innovative approach to cost management and data..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a Promising 54% Upside Potential

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company based in Warminster, Pennsylvania, is catching the attention of investors with a compelling potential upside of 54.43%...

Regulus Therapeutics Inc. (RGLS) Stock Analysis: A Biotech with 7.19% Upside Potential

Regulus Therapeutics Inc. (NASDAQ: RGLS) presents an intriguing proposition for investors seeking opportunities in the biotechnology sector. With its current market cap of $568.41 million, Regulus..

Personalis, Inc. (PSNL) Stock Analysis: Riding the Wave of Genomic Innovation with 7.20% Upside Potential

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector, specifically within the diagnostics and research industry, has been making waves with its innovative approaches..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 315.82% Upside in the Biotech Arena

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is garnering significant attention in the biotechnology sector, primarily due to its innovative approach in developing therapies targeting G protein-coupled receptors..

Definitive Healthcare Corp. (DH) Stock Analysis: Evaluating the 7.89% Potential Upside in the Healthcare Information Sector

Definitive Healthcare Corp. (NASDAQ: DH) presents an intriguing proposition for investors eyeing the healthcare information services sector. As a provider of a comprehensive software-as-a-service (SaaS) healthcare..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth and Challenges in Senior Care

Sonida Senior Living, Inc. (SNDA) operates within the healthcare sector, specifically focusing on medical care facilities. Based in Dallas, Texas, this company provides essential services for..

Nutex Health Inc. (NUTX) Investor Outlook: Unpacking a Potential 108.68% Upside

Nutex Health Inc. (NASDAQ: NUTX), a dynamic player in the healthcare sector, is capturing investor attention with a potential upside of 108.68%, according to analyst target..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Closer Look at Its Strong Forward P/E and High RSI

For investors looking to explore opportunities in the healthcare sector, SIGA Technologies Inc. (SIGA) presents an intriguing case. Specializing in the health security market, this commercial-stage..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 324% Potential Upside with Robust Revenue Growth

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing attention in the biotechnology sector with its ambitious focus on genetic medicines aimed at addressing serious diseases. As a..

Verastem, Inc. (VSTM) Stock Analysis: A 203% Upside Potential in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a pioneering player in the biotechnology industry, is making waves with its ambitious focus on cancer treatment. Headquartered in Needham, Massachusetts, Verastem..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 122% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is capturing investor attention with its robust potential upside of 122.02%, according to recent analyst ratings. The clinical-stage biopharmaceutical company is..

Cel-Sci Corporation (CVM) Investor Outlook: Examining a Potential 10,381% Upside in the Biotech Space

Cel-Sci Corporation (NYSE American: CVM) is a name that has piqued the interest of speculative investors in the biotech sector, primarily thanks to an eye-catching potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds